PMEL and melanoma: Thus, we comparatively explored the expression not only of Melan-A/MART-1 and gp100 but also of tyrosinase genes, encoding differentiation antigens widely used in active specific immunotherapy (Zajac et al, 2003) in HBL and D10 melanoma cells cultured in either MCTS or conventional 2D conditions.